Literature DB >> 24985155

Bovine herpesvirus type 1 marker vaccine induces cross-protection against bubaline herpesvirus type 1 in water buffalo.

Serena Montagnaro1, Claudio De Martinis2, Valentina Iovane2, Roberto Ciarcia2, Sara Damiano2, Sandra Nizza2, Luisa De Martino2, Giuseppe Iovane2, Ugo Pagnini2.   

Abstract

Water buffalo (Bubalus bubalis) are susceptible to bovine herpesvirus type 1 (BoHV-1) and a species-specific herpesvirus, bubaline herpesvirus type 1 (BuHV-1). In this study, an attenuated marker BoHV-1 based vaccine against BuHV-1 challenge was evaluated to determine whether it induces protection from viral replication. One group of water buffalo calves was immunized with an attenuated BoHV-1 marker vaccine. A second group was not vaccinated and used as the control. During the post-vaccination period, we monitored the humoral immune response. The efficacy of the vaccine was tested after intranasal challenge of the calves with a BuHV-1 strain. The experiment showed that after vaccination, BuHV-1 replication was significantly reduced by approximately three titer points compared to the controls. The control animals showed high levels of viral shedding and mild signs associated with BuHV-1 infection. Therefore, our study provides evidence for the existence of cross-protection between BoHV-1 and BuHV-1 in buffalo calves.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BoHV-1; BuHV-1; Marker vaccine; Water buffalo

Mesh:

Substances:

Year:  2014        PMID: 24985155     DOI: 10.1016/j.prevetmed.2014.06.002

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  2 in total

1.  Cattle are a potential reservoir of bubaline herpesvirus 1 (BuHV1).

Authors:  S S Maidana; F Delgado; L Vagnoni; A Mauroy; E Thiry; S Romera
Journal:  Vet Rec Open       Date:  2016-12-12

2.  Assessment of Different Infectious Bovine Rhinotracheitis Marker Vaccines in Calves.

Authors:  Stefano Petrini; Alessandra Martucciello; Cecilia Righi; Giovanna Cappelli; Claudia Torresi; Carlo Grassi; Eleonora Scoccia; Giulia Costantino; Cristina Casciari; Roberto Sabato; Monica Giammarioli; Esterina De Carlo; Francesco Feliziani
Journal:  Vaccines (Basel)       Date:  2022-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.